What is CrowdMed?
CrowdMed operates as a digital health platform designed to tackle challenging medical cases by leveraging a global network of medical professionals, referred to as 'medical detectives.' Patients can submit detailed medical histories and symptom descriptions, which are then analyzed by this community to generate diagnostic suggestions. These insights are intended to guide patients and their treating physicians toward more accurate and efficient diagnostic pathways. The platform supports users in over 30 countries and also provides marketing automation solutions to enhance business advertising campaigns, aiming to optimize and scale outreach efforts.
How much funding has CrowdMed raised?
CrowdMed has raised a total of $3.2M across 5 funding rounds:
Other Financing Round
$80K
Angel/Seed
$1.1M
Other Financing Round
$1.2M
Other Financing Round
$765K
Debt
$20K
Other Financing Round (2012): $80K with participation from Jared Heyman
Angel/Seed (2013): $1.1M led by Y Combinator, Greylock Partners, Andreessen Horowitz, and SV Angel
Other Financing Round (2013): $1.2M supported by Sheel Tyle, Elad Gil, Knight Enterprise Fund, Sam Altman, Matt Huang, and Khosla Ventures
Other Financing Round (2015): $765K featuring Knight Enterprise Fund, Arab Angel Fund, Patrick Dempsey, Y Combinator, Khosla Ventures, Greylock Partners, SV Angel, and Anne Wojcicki
Debt (2021): $20K backed by PPP
Key Investors in CrowdMed
Knight Enterprise Fund
Knight Foundation is a national foundation focused on journalism, the arts, and city success, aiming to foster informed and engaged communities essential for a healthy democracy.
Y Combinator
Y Combinator is a startup accelerator that provides seed funding and mentorship to early-stage companies, helping them to grow and scale their businesses.
Khosla Ventures
Khosla Ventures is a venture capital firm that provides funding and strategic advice to entrepreneurs working on breakthrough technologies across various sectors including AI, fintech, and health.
What's next for CrowdMed?
With the recent influx of substantial expansion capital, CrowdMed is poised for significant scaling of its operations and market reach. The company's focus on streamlining complex medical case resolution and its international presence suggest strategic initiatives aimed at enhancing platform capabilities, expanding its network of medical detectives, and potentially entering new geographic markets. This major enterprise-level funding will likely fuel technological advancements in its diagnostic support tools and bolster its marketing automation services, reinforcing its position in the digital health sector.
See full CrowdMed company page
